ERBB2 and cancer: Pharmacological inhibition of EGFR/HER2 was shown to activate AMPK in cancer cells (Spector et al. 2007), indirectly suggesting that EGFR and AMPK may exert functionally opposing effects on the Tyr10 phosphorylation.